Remove market-access news
article thumbnail

Cell Therapy Now Set to Reach More Patients With Expanded FDA Nod for 2 Multiple Myeloma Drugs

MedCity News

The expanded FDA approvals makes these cell therapies more accessible to more patients, broadening the market for both products. The post Cell Therapy Now Set to Reach More Patients With Expanded FDA Nod for 2 Multiple Myeloma Drugs appeared first on MedCity News.

FDA 125
article thumbnail

Aggregation in pharma: A must have for supply chain traceability

Pharmaceutical Commerce

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

State Prescription Drug Affordability Boards: A Road of Good Intentions Paved with Price Controls & Contract Impairment

Pharmaceutical Commerce

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

article thumbnail

News Release: Clarify Health Launches Clarify Access, a Software Solution to Generate On-Demand Market Access Reports, Delivering Robust Payer Insights and Intelligence to Pharma Industry

Clarify Health

Clarify Health, a leading cloud analytics and value-based payments platform company, announced the launch of Clarify Access , real-world insights software that helps life sciences companies strengthen market access strategies and improve reporting efficiency through the delivery of on-demand reporting and payer insights.

article thumbnail

News Release: Clarify Health Launches Clarify Access, a Software Solution to Generate On-Demand Market Access Reports, Delivering Robust Payer Insights and Intelligence to Pharma Industry

Clarify Health

With Clarify Access, pharma teams can more rapidly adjust market access strategies, instantly pinpoint formulary advantages and weaknesses to better enable their field force and save time during contract negotiations with specific payers.

article thumbnail

Biogen continues to sink

World of DTC Marketing

According to Endpoint News” We’ve seen Biogen’s CSO exit under pressure in recent weeks, and senior marketing execs leave in an exodus as the company recoiled from a fierce backlash against the FDA’s ultra controversial approval of Aduhelm for Alzheimer’s. Click to Tweet.

Marketing 253
article thumbnail

Establishing A Cleanroom that Meets Good Manufacturing Practice (GMP) Guidelines

Pharmaceutical Commerce

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.